Participants who understand their trial stay in their trial.
Clear Trials transforms complex clinical trial documents into accessible, ongoing resources—helping participants and caregivers navigate every step from enrollment to completion.
The Problem
Clinical trial consent forms average a 10th–14th grade reading level. Most participants read at a 7th–8th grade level. Only 8% of consent forms meet recommended readability standards.
This isn't a paperwork problem. It's a comprehension problem—and it drives 35% of participant dropout.
Coordinators spend 5–8 hours each week answering the same questions: “When is my next visit?” “I lost my medication instructions.” “Is this side effect normal?” Meanwhile, participants and caregivers are left searching paper handouts and PDFs for answers they needed yesterday.
What We Believe
Document simplification is a feature. Reducing the cognitive load of being in a clinical trial is the product.
Participants leave enrollment overwhelmed, unsure what they actually agreed to. They forget instructions given weeks ago. They experience symptoms and don't know if they're expected. They show up to visits unprepared. They can't explain what's happening to the people supporting them.
We believe that when participants truly understand their trial—what's expected, what's normal, what's next—they stay engaged, prepared, and committed.
What Clear Trials Does
We pick up where informed consent ends.
Clear Trials makes IRB-approved materials accessible throughout the trial—not just at enrollment. We transform complex documents into plain-language resources that participants and caregivers can access 24/7.
When questions arise at 10pm, participants type naturally: “Can I take ibuprofen?” or “What happens at my next visit?” They get relevant passages from their actual documents with source attribution. No hallucination risk. The documents stay the source of truth.
For decentralized and hybrid trials, where participants manage procedures at home, this becomes essential infrastructure. Paper handouts aren't sufficient when instructions must be followed weeks later, outside the clinic.
How We're Different
We're the only platform focused entirely on participant comprehension throughout the trial lifecycle.
We're not recruitment.
We support participants after enrollment.
We're not eConsent.
We support comprehension after the signature.
We're not ePRO.
We focus on understanding, not data collection.
We're not a chatbot.
Documents remain the source of truth.
Meet the Founders
Brian Blackmon
Co-Founder & CEO
Brian is a clinical research leader with deep experience in innovation and operations. As Innovation Manager at the Duke Clinical Research Institute, he works with innovators and industry experts to scale ideas that improve how research works. His mission is personal: watching his father struggle to navigate a clinical trial revealed the gap Clear Trials was built to close.
Andy Busam
Co-Founder & CTO
Andy is a technical leader specializing in digital health. At Method, a digital product consultancy, he leads the healthcare and life sciences portfolio—overseeing product strategy and delivery across med tech, life sciences, and consumer health. Previously Director of Digital Strategy at United Therapeutics, he brings the platform-building rigor behind Clear Trials.
Join Our Advisory Panel
Whether you're a trial participant, caregiver, site coordinator, or research professional—your perspective shapes what we build. Get early access to the platform and help us design tools that actually work for the people who use them.
Apply to JoinOur Commitment
Clear Trials maintains strict regulatory compliance. Our AI never minimizes risks, adds claims not present in source documents, or uses promotional language. Every transformation adheres to ICH GCP, FDA 21 CFR 50.25, and EU Clinical Trials Regulation standards.
We exist to help participants understand what they signed up for—accurately, accessibly, and throughout their journey.